The study showed OncoPrism-NSCLC significantly predicted overall response and identified the subset of patients with doubled median overall survival i ...

Prioritize NGS, liquid biopsy, AI-driven interpretation and strategic partnerships to capitalize on precision oncology, companion diagnostics and early detection.Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) ...

Limiting inherited genetic testing to younger people with cancer would have missed most of those who carry a cancer-risk gene ...

Germline genetic screening can identify whether a patient with cancer has inherited genetic alterations in a gene or genes ...

Prosigna is available as a laboratory-developed test through Veracyte’s CLIA-certified laboratory in San Diego. The Veracyte Access Program offers financial assistance or tailored payment plans for ...

Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...

Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say. A person’s genes don’t change. But testing has come a long way, and many early tests ...

A new FDA decision and a jump in gene-panel technology are quietly changing what an old “all-clear” really means.

A randomized trial at MD Anderson Cancer Center found that personalized navigation support raised BRCA genetic testing uptake ...

Thousands of women diagnosed with early-stage breast cancer who would once have been sent straight to chemotherapy can now skip it entirely, guided by gene-expression tests that measure the biology of ...

However, applying a conventional age-based testing threshold would have substantially reduced the number of patients identified. Restricting testing to patients diagnosed before age 50 would have ...